Current Hepatitis Reports

Acute HCV: Will IL28B Testing Change the Paradigm?
Boceprevir versus Telaprevir: A New Era of Directly Acting Antiviral Therapy
HCV and Chemotherapy: Does Infection Change Management?
HCV In At Risk Populations: Who Can be Treated and How?
HCV Therapy in 2011: Development of New Treatment Paradigms for Naïve and Non-Responder Patients
IL28B: Implications for Clinical Practice
The Role of Iron in Hepatitis C Infection